Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Seagen Inc. | a10k2019.htm |
| EX-32.2 - EXHIBIT 32.2 - Seagen Inc. | ex-322201910k.htm |
| EX-32.1 - EXHIBIT 32.1 - Seagen Inc. | ex-321201910k.htm |
| EX-31.2 - EXHIBIT 31.2 - Seagen Inc. | ex-312201910k.htm |
| EX-31.1 - EXHIBIT 31.1 - Seagen Inc. | ex-311201910k.htm |
| EX-23.1 - EXHIBIT 23.1 - Seagen Inc. | ex-231201910k.htm |
| EX-10.88 - EXHIBIT 10.88 - Seagen Inc. | ex-1088201910k.htm |
| EX-10.87 - EXHIBIT 10.87 - Seagen Inc. | ex-1087201910k.htm |
| EX-10.86 - EXHIBIT 10.86 - Seagen Inc. | ex-1086201910k.htm |
| EX-10.85 - EXHIBIT 10.85 - Seagen Inc. | ex-1085201910k.htm |
| EX-10.84 - EXHIBIT 10.84 - Seagen Inc. | ex-1084201910k.htm |
| EX-10.83 - EXHIBIT 10.83 - Seagen Inc. | ex-1083201910k.htm |
| EX-10.82 - EXHIBIT 10.82 - Seagen Inc. | ex-1082201910k.htm |
| EX-10.81 - EXHIBIT 10.81 - Seagen Inc. | ex-1081201910k.htm |
| EX-10.80 - EXHIBIT 10.80 - Seagen Inc. | ex-1080201910k.htm |
| EX-10.29 - EXHIBIT 10.29 - Seagen Inc. | ex-1029201910k.htm |
| EX-10.1 - EXHIBIT 10.1 - Seagen Inc. | ex-101201910k.htm |
| EX-4.1 - EXHIBIT 4.1 - Seagen Inc. | ex-41201910k.htm |
Exhibit 21.1
Subsidiaries of Seattle Genetics, Inc.
Name | Jurisdiction of Incorporation | |
Seagen Canada, Inc. | Canada | |
Seattle Genetics UK, Limited | England and Wales | |
SeaGen International GmbH | Switzerland | |
Seagen Ireland Limited | Ireland | |
Seagen Netherlands B.V. | Netherlands | |
Seagen Germany GmbH | Germany | |
Seagen Denmark ApS | Denmark | |
Seagen Italy S.r.l. | Italy | |
Seagen France SARL | France | |
East Coast Ventures, Inc. | Delaware | |
Cascadian Therapeutics, Inc. | Delaware | |
SeaGen International Holdings, LLC | Delaware | |
SeaGen US Holdings, LLC | Delaware | |
SeaGen, Inc. | Delaware | |
Biomira Management, Inc. | Delaware | |
Protocell Therapeutics, Inc. | Delaware | |
ProlX Pharmaceuticals Corporation | Delaware | |
0811769 B.C. ULC | Canada | |
Cascadian Therapeutics Luxembourg | Luxembourg | |
Oncothyreon Canada ULC | Canada | |